Differential involvement of hippocampal vasoactive intestinal peptide in nociception of rats with a model of depression

Peptides

Volumn 30, Issue 8, 2009, Pages 1497-1501

  Belcheva, Iren ^a   Ivanova, Margarita ^b   Tashev, Roman ^a   Belcheva, Stiliana ^a  

^a BULGARIAN ACADEMY OF SCIENCES   (Bulgaria)

^b MEDICAL UNIVERSITY OF VARNA   (Bulgaria)

Author keywords

Depression; Hippocampus; Nociception; Olfactory bulbectomy; Vasoactive intestinal peptide

Indexed keywords

VASOACTIVE INTESTINAL POLYPEPTIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DEPRESSION; DISEASE MODEL; HEMISPHERIC DOMINANCE; HIPPOCAMPUS; MALE; MECHANICAL STRESS; MICROINJECTION; NOCICEPTION; NONHUMAN; OLFACTORY BULBECTOMY; PAIN THRESHOLD; PRIORITY JOURNAL; RAT;

ANIMALS; DEPRESSION; DISEASE MODELS, ANIMAL; HIPPOCAMPUS; MALE; OLFACTORY BULB; PAIN MEASUREMENT; RATS; RATS, WISTAR; VASOACTIVE INTESTINAL PEPTIDE;

RATTUS; RATTUS NORVEGICUS;

EID: 67650403341     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2009.05.015     Document Type: Article

References (70)

1. Acsády L., Arabadzisz D., and Freund T.F. Correlated morphological and neurochemical features identify different subsets of vasoactive intestinal polypeptide-immunoreactive interneurons in the rat hippocampus. Neuroscience 73 (1996) 299-315
2. Aton S.J., Colwell C.S., Harmar A.J., Waschek J., and Herzog E.D. Vasoactive intestinal polypeptide mediates circadian rhythmicity and synchrony in mammalian clock neurons. Nat Neurosci 8 (2005) 476-483
3. Bär K.J., and Greiner W. Pain perception is not influenced by altered autonomic function in major depression. Psychiatr Prax 34 Suppl 3 (2007) S309-313
4. Belcheva I., Belcheva S., Petkov V.V., and Petkov V.D. Hippocampal asymmetry in the behavioral responses to the 5-HT1A receptor agonist 8-OH-DPAT. Brain Res 640 (1994) 223-228
5. Belcheva I., Chobanova M., and Georgiev V. Differential behavioral effects of angiotensin II microinjected unilaterally into the CA1 hippocampal area. Regul Peptides 74 (1998) 67-71
6. Belcheva I., Ternianov A., and Georgiev V. Lateralized learning and memory effects of angiotensin II microinjected into the rat CA1 hippocampal area. Peptides 21 (2000) 407-411
7. Belcheva I., Tashev R., and Belcheva S. Hippocampal asymmetry in serotonergic modulation of learning and memory in rats. Laterality 12 (2007) 475-486
8. Belcheva S., Tashev R., Hadjiivanova C., and Belcheva I. Modulation of learning and memory by CI-988 cholecystokinin octapeptide antagonist microinjected into CA1 hippocampal area. Compt Rend Acad Bulg Sci 60 12 (2007) 1337-1342
9. Besson J., Sarrieau A., Vial M., Marie J.C., Rosselin G., and Rostene W. Characterization and autoradiographic distribution of vasoactive intestinal peptide binding sites in the rat central nervous system. Brain Res 398 (1986) 329-336
10. Bobkova N.V., Nesterova I.V., and Nesterov V.V. The state of cholinergic structures in forebrain of bulbectomized mice. Bull Exp Biol Med 131 (2001) 427-431
11. Bobkova N., Vorobyov V., Medvinskaya N., Aleksandrova I., and Nesterova I. Interhemispheric EEG differences in olfactory bulbectomized rats with different cognitive abilities and brain beta-amyloid levels. Brain Res 1232 (2008) 185-194
12. Brenneman D.E., Hauser J., Phillips T.M., Davidson A., Bassan M., and Gozes I. Vasoactive intestinal peptide. Link between electrical activity and glia-mediated neurotrophism. Ann N Y Acad Sci 897 (1999) 17-26
13. Capurso S.A., Calhoun M.E., Sukhov R.R., Mouton P.R., Price D.L., and Koliatsos V.E. Differentiation causes apoptosis in cortical sensory neurons in the adult rat. J Neurosci 17 (1997) 7372-7384
14. Carlsen J., De Olmos J., and Heimer L. Tracing of two-neuron pathways in the olfactory system by the aid of transneuronal degeneration: projections to the amygdaloid body and hippocampal formation. J Comp Neurol 208 (1982) 196-208
15. Chudler E.H., and Dong W.K. The role of the basal ganglia in nociception and pain. Pain 60 (1995) 3-38
16. Ciranna L., and Cavallaro S. Opposing effects by pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal peptide on hippocampal synaptic transmission. Exp Neurol l184 (2003) 778-784
17. Collins G.G. Amino acid transmitter candidates in various regions of the primary olfactory cortex following bulbectomy. Brain Res 296 (1984) 145-147
18. Cunha-Reis D., Sebastiao A.M., Wirkner K., Illes P., and Ribeiro J.A. VIP enhances both pre- and postsynaptic GABAergic transmission to hippocampal interneurones leading to increased excitatory synaptic transmission to CA1 pyramidal cells. Br J Pharmacol 143 (2004) 733-744
19. Dickinson T., and Fleetwood-Walker S.M. VIP and PACAP: very important in pain?. Trends Pharmacol Sci 20 (1999) 324-329
20. Edvinsson L. A pathophysiological view of primary headaches. Funct Neurol 15 (2000) 50-60
21. Giordano J. The neurobiology of nociceptive and anti-nociceptive systems. Pain Phys 8 (2005) 277-290
22. Gjerris A., Rafaelsen O.J., Vendsborg P., Fahrenkrug J., and Rehfeld J.F. Vasoactive intestinal polypeptide decreased in cerebrospinal fluid (CSF) in atypical depression. Vasoactive intestinal polypeptide, cholecystokinin and gastrin in CSF in psychiatric disorders. J Affect Disord 7 (1984) 325-337
23. Gozes I., and Brenneman D.E. VIP: molecular biology and neurobiological function. Mol Neurobiol 3 (1989) 201-236
24. Haas H.L., and Gahwiler B.H. Vasoactive intestinal polypeptide modulates neuronal excitability in hippocampal slices of the rat. Neuroscience 47 (1992) 273-277
25. Harmar A.J., Arimura A., Gozes I., Journot L., Laburthe M., Pisegna J.R., et al. International union of pharmacology. XVIII. Nomenclature of receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide. Pharmacol Rev 50 2 (1998) 265-270
26. Harvey J.A., Scholfield C.N., Grahm Jr. L.T., and Aprison M.H. Putative transmitters in denervated olfactory complex. J Neurochem 24 (1975) 445-449
27. Henn F.A., and Vollmayr B. Basic pathophysiological mechanisms in depression: what are they and how might they affect the course of illness?. Pharmacopsychiatry 37 (2004) 152-156
28. Holmes P.V. Olfactory bulbectomy increases prepro-enkephalin mRNA levels in the ventral striatum in rats. Neuropeptides 33 (1999) 206-211
29. Ishihara T., Shigemoto R., Mori K., Takahashi K., and Nagata S. Functional expression and tissue distribution of a novel receptor for vasoactive intestinal polypeptide. Neuron 8 (1992) 811-819
30. Itoh S., Katsuura G., and Takashima A. Effect of vasoactive intestinal peptide on dopaminergic system in the rat brain. Peptides 9 (1988) 315-317
31. Ivanova M., Ternianov A., Belcheva S., Tashev R., Negrev N., and Belcheva I. Hippocampal asymmetry in exploratory behavior to vasoactive intestinal polypeptide. Peptides 29 (2008) 940-947
32. Jancsar S.M., and Leonard B.E. Changes in neurotransmitter metabolism following olfactory bulbectomy in the rat. Prog Neuropsychopharmacol Biol Psychiatry 8 (1984) 263-269
33. Jeftinija S., Murase K., Nedeljkov V., and Randic M. Vasoactive intestinal polypeptide excites mammalian dorsal horn neurons both in vivo and in vitro. Brain Res 243 (1982) 158-164
34. Jolkkonen J., Hartikainen P., Soikkeli R., Bissette G., Nemeroff C., and Riekkinen P.A. Correlation study of CSF neuropeptides in Alzheimer's and Parkinson's disease. Neuropeptides 19 (1991) 97-102
35. Khanna S., Chang L.S., Jiang F., and Koh H.C. Nociception-driven decreased induction of Fos protein in ventral hippocampus field CA1 of the rat. Brain Res 1004 (2004) 167-176
36. Kelly J.P., Wrynn A., and Leonard B.E. The olfactory bulbectomized rat as a model of depression: an update. Pharmacol Ther 74 (1997) 299-316
37. Komisaruk B.R., Banas C., and Heller S.B. Analgesia produced by vasoactive intestinal peptide administered directly to the spinal cord in rats. Ann N Y Acad Sci 527 (1986) 650-654
38. Lautenbacher S., Roscher S., Strian D., Fassbender K., Krumrey K., and Krieg J.C. Pain perception in depression: relationships to symptomatology and naloxone-sensitive mechanisms. Psychosom Med 56 (1994) 345-352
39. Lautenbacher S., Spernal J., Schreiber W., and Krieg J.C. Relationship between clinical pain complaints and pain sensitivity in patients with depression and panic disorder. Psychosom Med 61 (1999) 822-827
40. Lorén I., Emson P.C., Fahrenkrug J., Björklund A., Alumets J., Håkanson R., et al. Distribution of vasoactive intestinal polypeptide in the rat and mouse brain. Neuroscience 4 (1979) 1953-1976
41. Macsai M., Szabo G., and Telegdy G. Vasoactive intestinal polypeptide induces analgesia and impairs the antinociceptive effect of morphine in mice. Neuropeptides 32 (1998) 557-562
42. 17]vasoactive intestinal peptide binding sites in the rat brain. Neuroscience 23 (1987) 539-565
43. Masuo Y., Matsumoto Y., Tokito F., Tsuda M., and Fujino M. Effects of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) on the spontaneous release of acetylcholine from the rat hippocampus by brain microdialysis. Brain Res 611 (1993) 207-215
44. Matsuda K., and Maruyama K. Regulation of feeding behavior by pituitary adenylate cyclase-activating polypeptide (PACAP) and vasoactive intestinal polypeptide (VIP) in vertebrates. Peptides 28 (2007) 1761-1766
45. Miyachi Y. Analgesia induced by repeated exposure to low dose x-rays in mice, and involvement of the accessory olfactory system in modulation of the radiation effects. Brain Res Bull 44 (1997) 177-182
46. Nakagawasai O., Hozumi S., Tan-No K., Niijima F., Arai Y., Yasuhara H., et al. Immunohistochemical fluorescence intensity reduction of brain somatostatin in the impairment of learning and memory-related behaviour induced by olfactory bulbectomy. Behav Brain Res 142 (2003) 63-67
47. Nesterova I.V., Bobkova N.V., Medvinskaia N.I., Samokhin A.N., and Aleksandrova I.I. Morpho-functional state of neurons in temporal cortex and hippocampus in bulbectomized rats with different level of spatial memory. Morfologiia 131 (2007) 32-36
48. Nesterova I.V., Gurevich E.V., Nesterov V.I., Otmakhova N.A., and Bobkova N.V. Bulbectomy-induced loss of raphe neurons is counteracted by antidepressant treatment. Prog Neuropsychopharmacol Biol Psychiatry 21 (1997) 127-140
49. Pellegrino L.J., and Cushman A.J. A stereotaxic atlas of the rat brain (1967), Appleton, New York
50. Primeaux S.D., and Holmes P.V. Olfactory bulbectomy increases Met-enkephalin- and neuropeptide-Y-like immunoreactivity in rat limbic structures. Pharmacol Biochem Behav 67 (2000) 331-337
51. Randall L.O., and Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch Int Pharmacodyn Ther 111 (1957) 409-419
52. Romanova G.A., and Karganov M.I. The regulatory effect of VIP on exploratory behavior of the rat and on the neuromediator level in the normal brain and in frontal lobectomy. Fiziol Zh SSSR Im. I. M. Sechenova 75 (1989) 670-676
53. Rostene W.H., Fischette C.T., and McEwen B.S. Modulation by vasoactive intestinal peptide (VIP) of serotonin receptors in membranes from rat hippocampus. J Neurosci 12 (1983) 2414-2419
54. Said S.I. Vasoactive intestinal peptide. J Endocrinol Invest 9 (1986) 191-200
55. Said S.I., and Mutt V. Polypeptide with broad biological activity: isolation from small intestine. Science 169 (1970) 1217-1218
56. Sapolsky R.M. Is impaired neurogenesis relevant to the affective symptoms of depression?. Biol Psychiatry 56 (2004) 137-139
57. Scholfield C.N., Moroni F., Corradetti R., and Pepeu G. Levels and synthesis of glutamate and aspartate in the olfactory cortex following bulbectomy. J Neurochem 41 (1983) 135-138
58. Sessle B.J., Hu J.W., Dubner R., and Lucier G.E. Functional properties of neurons in cat trigeminal subnucleus caudalis (medullary dorsal horn). II. Modulation of responses to noxious and nonnoxious stimuli by periaqueductal gray, nucleus raphe magnus, cerebral cortex, and afferent influences, and effects of naloxone. J Neurophysiol 45 (1981) 193-207
59. Sims K.B., Hoffman D.L., Said S.I., and Zimmerman E.A. Vasoactive intestinal polypeptide (VIP) in mouse and rat brain: an immunocytochemical study. Brain Res 186 1 (1980) 165-183
60. Song C., Earley B., and Leonard B.E. The effects of central administration of neuropeptide Y on behavior, neurotransmitter, and immune functions in the olfactory bulbectomized rat model of depression. Brain Behav Immun 10 (1996) 1-16
61. Song C., and Leonard B.E. The olfactory bulbectomised rat as a model of depression. Neurosci Biobehav Rev 29 (2005) 627-647
62. Staines D.R. Is Parkinson's disease an autoimmune disorder of endogenous vasoactive neuropeptides?. Med Hypotheses 69 (2007) 1208-1211
63. Ternianov A., Kalfin R., and Belcheva I. Antinociceptive effect of vasoactive intestinal peptide (VIP) microinjected into the rats CA1 hippocampal area. C. R. Acad. Bulg. Sci 54 8 (2001) 95-96
64. Van der Stelt H.M., Breuer M.E., Olivier B., and Westenberg H.G. Permanent deficits in serotonergic functioning of olfactory bulbectomized rats: an in vivo microdialysis study. Biol Psychiatry 57 (2005) 1061-1067
65. Van Riezen H., Schnieden H., and Wren A.F. Olfactory bulb ablation in the rat: behavioural changes and their reversal by antidepressant drugs. Br J Pharmacol 60 (1977) 521-528
66. Vertongen P., Schiffmann S.N., Gourlet P., and Robberecht P. Autoradiographic visualization of the receptor subclasses for vasoactive intestinal polypeptide (VIP) in rat brain. Peptides 18 (1997) 1547-1554
67. Wang H.L., Li A., and Wu T. Vasoactive intestinal polypeptide enhances the GABAergic synaptic transmission in cultured hippocampal neurons. Brain Res 746 (1997) 294-300
68. Wrynn A.S., MacSweeney C.P., and Franconi F. An in vivo magnetic resonance imaging study of the olfactory bulbectomized rat model of depression. Brain Res 879 (2000) 193-199
69. Yoshimura H., Gomita Y., and Ueki S. Changes in acetylcholine content in rat brain after bilateral olfactory bulbectomy in relation to mouse-killing behaviour. Pharmacol Biochem Behav 2 (1974) 703-705
70. Zheng F., and Khanna S. Hippocampal field CA1 interneuronal nociceptive responses: modulation by medial septal region and morphine. Neuroscience 93 (1999) 45-55